Mustang Bio (MBIO) Capital Expenditures (2017 - 2023)
Mustang Bio (MBIO) posted quarterly Capital Expenditures of $30000.0 for Q4 2023, down 68.42% year-over-year from $95000.0 in Q4 2022, and up 87.5% quarter-over-quarter from $16000.0 in Q2 2023.
Mustang Bio (MBIO) Capital Expenditures (2017 - 2023) Analysis & Trends
Mustang Bio (MBIO) has reported Capital Expenditures for 7 consecutive years, with $30000.0 the latest figure, recorded in Q4 2023.
- In Q4 2023, Capital Expenditures fell 68.42% year-over-year to $30000.0; the TTM figure through Sep 2024 stood at $30000.0 (down 76.74% YoY), while the FY2023 annual figure was $64000.0, down 97.64% from the prior year.
- Capital Expenditures grew to $30000.0 in Q4 2023 per MBIO's latest filing, from $16000.0 in the prior quarter.
- Across five years, Capital Expenditures topped out at $1.7 million in Q2 2021 and bottomed at -$1.3 million in Q4 2021.
- Historically, Capital Expenditures has averaged $324210.5 across 5 years, with a median of $190000.0 in 2020.
- Annual changes were most pronounced in 2019 — Capital Expenditures plunged 516.78% — and 2021, when it surged 523.81%.
- Mustang Bio's Capital Expenditures stood at -$1.3 million in 2019, then soared by 226.91% to $1.6 million in 2020, then sank by 183.27% to -$1.3 million in 2021, then surged by 107.09% to $95000.0 in 2022, then tumbled by 68.42% to $30000.0 in 2023.
- Business Quant data shows MBIO's Capital Expenditures at $30000.0 in Q4 2023, $16000.0 in Q2 2023, and $18000.0 in Q1 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 140.23 Bn | 132.38 Bn | 2.84 Bn | 112.20 Mn |
| 2 | Regeneron Pharmaceuticals | 86.97 Bn | 78.97 Bn | 3.93 Bn | 240.20 Mn |
| 3 | Argenx Se | 65.29 Bn | 60.11 Bn | 1.37 Bn | - |
| 4 | Moderna | 59.88 Bn | 54.74 Bn | 52.00 Mn | 37.00 Mn |
| 5 | BeOne Medicines | 42.20 Bn | 37.11 Bn | 1.53 Bn | 25.02 Mn |
| 6 | Alnylam Pharmaceuticals | 31.62 Bn | 28.31 Bn | 992.69 Mn | 34.68 Mn |
| 7 | BioNTech SE | 28.69 Bn | 10.30 Bn | 668.28 Mn | -73.57 Mn |
| 8 | Insmed | 27.51 Bn | 26.35 Bn | 358.27 Mn | 6.26 Mn |
| 9 | Royalty Pharma | 27.16 Bn | 26.33 Bn | - | 251.02 Mn |
| 10 | Mustang Bio | 3.86 Mn | 3.86 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 30,000.00 |
| Dec 31, 2023 | 30,000.00 |
| Jun 30, 2023 | 16,000.00 |
| Jun 30, 2023 | 16,000.00 |
| Mar 31, 2023 | 18,000.00 |
| Mar 31, 2023 | 18,000.00 |
| Dec 31, 2022 | 95,000.00 |
| Dec 31, 2022 | 95,000.00 |
| Sep 30, 2022 | 979,000.00 |
| Sep 30, 2022 | 979,000.00 |
| Jun 30, 2022 | 1.61 Mn |
| Jun 30, 2022 | 1.61 Mn |
| Mar 31, 2022 | 35,000.00 |
| Mar 31, 2022 | 35,000.00 |
| Dec 31, 2021 | -1.34 Mn |
| Dec 31, 2021 | -1.34 Mn |
| Sep 30, 2021 | 460,000.00 |
| Sep 30, 2021 | 460,000.00 |
| Jun 30, 2021 | 1.69 Mn |
| Jun 30, 2021 | 1.69 Mn |